Weihong Lv

439 total citations · 1 hit paper
3 papers, 339 citations indexed

About

Weihong Lv is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Weihong Lv has authored 3 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Weihong Lv's work include Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers) and MicroRNA in disease regulation (1 paper). Weihong Lv is often cited by papers focused on Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers) and MicroRNA in disease regulation (1 paper). Weihong Lv collaborates with scholars based in China. Weihong Lv's co-authors include Wei Han, Wanming Hao, Kongmiao Lu, Min Liu, Sheng Wei, Xiao Zhang, Huaping Tang, Xiu Xin, Jingwen Li and Ling Li and has published in prestigious journals such as Journal of Translational Medicine, International Journal of Molecular Medicine and Frontiers in Nutrition.

In The Last Decade

Weihong Lv

2 papers receiving 338 citations

Hit Papers

Panaxydol attenuates ferroptosis against LPS-induced acut... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihong Lv China 2 212 172 125 63 22 3 339
Kongmiao Lu China 5 211 1.0× 175 1.0× 115 0.9× 60 1.0× 38 1.7× 8 366
Wanming Hao China 6 252 1.2× 198 1.2× 162 1.3× 82 1.3× 30 1.4× 11 443
Youjing Yang China 9 182 0.9× 140 0.8× 96 0.8× 32 0.5× 24 1.1× 19 306
Guangping Meng China 9 233 1.1× 94 0.5× 158 1.3× 45 0.7× 25 1.1× 13 436
Weibin Qian China 6 124 0.6× 157 0.9× 80 0.6× 31 0.5× 22 1.0× 7 299
Xinrui Cai China 11 155 0.7× 182 1.1× 103 0.8× 32 0.5× 41 1.9× 15 415
Nihong Lu China 7 252 1.2× 108 0.6× 197 1.6× 39 0.6× 25 1.1× 18 364
Yanmin Xia China 8 162 0.8× 60 0.3× 82 0.7× 41 0.7× 37 1.7× 16 298
Zhaohu Xie China 7 196 0.9× 53 0.3× 64 0.5× 32 0.5× 40 1.8× 18 332
Weirong Hu China 11 156 0.7× 65 0.4× 58 0.5× 29 0.5× 34 1.5× 26 317

Countries citing papers authored by Weihong Lv

Since Specialization
Citations

This map shows the geographic impact of Weihong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Lv more than expected).

Fields of papers citing papers by Weihong Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Lv. The network helps show where Weihong Lv may publish in the future.

Co-authorship network of co-authors of Weihong Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Lv. A scholar is included among the top collaborators of Weihong Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Lv. Weihong Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Li, Jingwen, et al.. (2025). Depression and diabetic retinopathy: an underexplored connection. Frontiers in Nutrition. 12. 1557105–1557105. 1 indexed citations
2.
Lu, Kongmiao, Xiao Zhang, Sheng Wei, et al.. (2021). Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway. Journal of Translational Medicine. 19(1). 96–96. 319 indexed citations breakdown →
3.
Tang, Huaping, et al.. (2018). miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells. International Journal of Molecular Medicine. 43(3). 1203–1216. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026